Literature DB >> 35754103

Recovery of dopaminergic system after cocaine exposure and impact of a long-acting cocaine hydrolase.

Jing Deng1,2, Ting Zhang1,2, Xirong Zheng1,2, Linyue Shang1,2, Chang-Guo Zhan1,2, Fang Zheng1,2.   

Abstract

Dysregulation of dopamine transporters (DAT) within the dopaminergic system is an important biomarker of cocaine exposure. Depending on cocaine amount in-taken, one-time exposure in rats could lead to most (>95% of total) of DAT translocating to plasma membrane of the dopaminergic neurons compared to normal DAT distribution (~5.7% on the plasma membrane). Without further cocaine exposure, the time course of striatal DAT distribution, in terms of intracellular and plasma membrane fractions of DAT, represents a recovery process of the dopaminergic system. In this study, we demonstrated that after an acute cocaine exposure of 20 mg/kg (i.p.), the initial recovery process from days 1 to 15 in rats was relatively faster (from >95% on day 1 to ~35.4% on day 15). However, complete recovery of the striatal DAT distribution may take about 60 days. In another situation, with repeated cocaine exposures for once every other day for a total of 17 doses of 20 mg/kg cocaine (i.p.) from days 0 to 32, the complete recovery of striatal DAT distribution may take an even longer time (about 90 days), which represents a consequence of chronic cocaine use. Further, we demonstrated that a highly efficient Fc-fused cocaine hydrolase, CocH5-Fc(M6), effectively blocked cocaine-induced hyperactivity and DAT trafficking with repeated cocaine exposures by maintaining a plasma CocH5-Fc(M6) concentration ≥58.7 ± 2.9 nM in rats. The cocaine hydrolase protected dopaminergic system and helped the cocaine-altered DAT distribution to recover by preventing the dopaminergic system from further damage by cocaine.
© 2022 Society for the Study of Addiction.

Entities:  

Keywords:  cocaine; cocaine hydrolase; dopamine transporter

Mesh:

Substances:

Year:  2022        PMID: 35754103      PMCID: PMC9245253          DOI: 10.1111/adb.13179

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.093


  41 in total

Review 1.  Plasma membrane monoamine transporters: structure, regulation and function.

Authors:  Gonzalo E Torres; Raul R Gainetdinov; Marc G Caron
Journal:  Nat Rev Neurosci       Date:  2003-01       Impact factor: 34.870

2.  Long-acting cocaine hydrolase for addiction therapy.

Authors:  Xiabin Chen; Liu Xue; Shurong Hou; Zhenyu Jin; Ting Zhang; Fang Zheng; Chang-Guo Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

3.  Dopamine transporter trafficking: rapid response on demand.

Authors:  Rong Chen; Cheryse A Furman; Margaret E Gnegy
Journal:  Future Neurol       Date:  2010-01-01

4.  Development of a long-acting Fc-fused cocaine hydrolase with improved yield of protein expression.

Authors:  Xiabin Chen; Jing Deng; Xirong Zheng; Jinling Zhang; Ziyuan Zhou; Huimei Wei; Chang-Guo Zhan; Fang Zheng
Journal:  Chem Biol Interact       Date:  2019-04-12       Impact factor: 5.192

Review 5.  Structure-and-mechanism-based design and discovery of therapeutics for cocaine overdose and addiction.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  Org Biomol Chem       Date:  2007-12-05       Impact factor: 3.876

6.  Dopamine and amphetamine rapidly increase dopamine transporter trafficking to the surface: live-cell imaging using total internal reflection fluorescence microscopy.

Authors:  Cheryse A Furman; Rong Chen; Bipasha Guptaroy; Minjia Zhang; Ronald W Holz; Margaret Gnegy
Journal:  J Neurosci       Date:  2009-03-11       Impact factor: 6.167

7.  Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT.

Authors:  R T Malison; S E Best; C H van Dyck; E F McCance; E A Wallace; M Laruelle; R M Baldwin; J P Seibyl; L H Price; T R Kosten; R B Innis
Journal:  Am J Psychiatry       Date:  1998-06       Impact factor: 18.112

8.  How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.

Authors:  Xiaoqin Huang; Chang-Guo Zhan
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

9.  Clinical potential of a rationally engineered enzyme for treatment of cocaine dependence: Long-lasting blocking of the psychostimulant, discriminative stimulus, and reinforcing effects of cocaine.

Authors:  Ting Zhang; Huimei Wei; Jing Deng; Fang Zheng; Chang-Guo Zhan
Journal:  Neuropharmacology       Date:  2020-07-22       Impact factor: 5.250

10.  A highly efficient cocaine-detoxifying enzyme obtained by computational design.

Authors:  Fang Zheng; Liu Xue; Shurong Hou; Junjun Liu; Max Zhan; Wenchao Yang; Chang-Guo Zhan
Journal:  Nat Commun       Date:  2014-03-18       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.